by David Sires | Jul 13, 2026 | Blog
Give this article a read: “Chronic Liver Disease: How PCPs Can Improve Early Detection.” This HCPLive interview with Stevan Gonzalez, MD, MS (Director of Liver Transplantation at Baylor Scott & White Health) is less of a research paper and more of a...
by Pete Celano | Jul 9, 2026 | Blog
Here’s a summary of the paper titled: Machine Learning–Assisted Detection of Advanced Liver Fibrosis in Primary Care (2025) One-sentence summary The study found that an AI/machine learning approach applied to routine primary care data substantially improved...
by David Sires | Jul 7, 2026 | Blog
The LinkedIn article titled “Trinity Health Aims to Improve Liver Cancer Screening Rates Through Physician, Patient Education Intervention” highlights a small but potentially high-impact initiative by Trinity Health West Michigan to improve hepatocellular...
by Pete Celano | Jul 3, 2026 | Blog
This new Clinical Gastroenterology and Hepatology (CGH) study is one of the strongest observational studies to date examining coffee and liver health because it combines long-term clinical outcomes with liver MRI imaging and blood proteomics, providing biologic...
by David Sires | Jul 1, 2026 | Blog
The PharmaVoice article titled “3 late-stage MASH drugs that could rival Rezdiffra” highlights the next wave of MASH therapies expected to compete with Madrigal’s Rezdiffra (resmetirom), emphasizing that the future of MASH treatment will likely...
by Brandon Tudor | Jun 29, 2026 | Blog
Here are the key takeaways from the HCPLive article, “Lifestyle, Pharmacologic Therapies, and EXCEL Trial Data Reshape MASLD Treatment Framework,” by Dr. Zobair Younossi (published June 23, 2026). 1. MASLD treatment is entering a new era The article argues...
